World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
43033
World Ranking
4995
National Ranking
2709

Larry E. Kun publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Larry E. Kun sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 487 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Larry E. Kun D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Larry E. Kun sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Larry E. Kun was affiliated with St. Jude Children's Research Hospital in the United States. Their research work primarily focused on multiple aspects of medicine, with an emphasis on rheumatology, pharmacology, hepatology, epidemiology, and surgery.

The scientist contributed to research in several main topics, including:

  • Rheumatoid Arthritis Research and Therapies
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Inflammatory mediators and NSAID effects
  • Histone Deacetylase Inhibitors Research
  • Cytokine Signaling Pathways and Interactions

They frequently published in these venues:

  • Annals of the Rheumatic Diseases
  • World Journal of Gastroenterology
  • Annals of Medical Research

They collaborated often with coauthors:

  • Erika Corberi
  • Francesca Trunfio
  • Francesca Saracino
  • Marta Vomero
  • Damiano Currado

Larry E. Kun's recent publications included:

  • "Machine learning prediction of hepatic encephalopathy for long-term survival after transjugular intrahepatic portosystemic shunt in acute variceal bleeding," 2024, published in World Journal of Gastroenterology
  • "POS1148 MECHANISMS OF PAIN MODULATION BY JAK INHIBITION: UPADACITINIB REGULATES PAIN-RELATED PATHWAYS AND BDNF EXPRESSION IN MICROGLIAL CELLS," 2024, Annals of the Rheumatic Diseases
  • "AB0133 FIBROMIND: THE USE OF MINDFULNESS-BASED STRESS REDUCTION INTERVENTION AS A POTENTIAL "ADD-ON THERAPY" TO THE USUAL TREATMENTS FOR THE MANAGEMENT OF FIBROMYALGIA AND ITS IMPACT ON HOPE LEVELS," 2024, Annals of the Rheumatic Diseases
  • "AB0713 PAIN CATASTROPHIZING AND ITS DOMAINS HELPLESSNESS AND RUMINATION IMPACT SIGNIFICANTLY ON DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: DATA FROM A MULTICENTER ITALIAN STUDY," 2024, Annals of the Rheumatic Diseases
  • "AB0926 PAIN CATASTROPHIZING NEGATIVELY IMPACTS DRUG RETENTION RATE IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: RESULTS FROM A 2-YEAR PERSPECTIVE MULTICENTER STUDY," 2024, Annals of the Rheumatic Diseases

Best Publications

  • Treating childhood acute lymphoblastic leukemia without cranial irradiation.

    Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman

  • Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

    Amar Gajjar;Murali Chintagumpala;David Ashley;Stewart Kellie

  • Late neurocognitive sequelae in survivors of brain tumours in childhood.

    Raymond K Mulhern;Thomas E Merchant;Amar Gajjar;Wilburn E Reddick

  • Postoperative Chemotherapy and Delayed Radiation in Children Less Than Three Years of Age With Malignant Brain Tumors

    Patricia K. Duffner;Marc E. Horowitz;Jeffrey P. Krischer;Henry S. Friedman

  • Radiation response of the central nervous system.

    T.E. Schultheiss;L.E. Kun;K.K. Ang;L.C. Stephens

  • Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

    Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana

  • Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.

    Peter C. Burger;I. T. Yu;Tarik Tihan;Henry S. Friedman

  • Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study

    Thomas E Merchant;Chenghong Li;Xiaoping Xiong;Larry E Kun

  • Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

    Ching Hon Pui;Cheng Cheng;Wing Leung;Shesh N. Rai

  • Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

    G.K. Rivera;G.K. Rivera;C.-H. Pui;C.-H. Pui;M. Abromowitch;M. Abromowitch;J. Mirro;J. Mirro

  • High incidence of secondary brain tumours after radiotherapy and antimetabolites

    Mary V. Relling;Mary V. Relling;Jeffrey E. Rubnitz;Jeffrey E. Rubnitz;Gaston K. Rivera;Gaston K. Rivera;James M. Boyett;James M. Boyett

  • Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma

    Raymond K. Mulhern;Shawna L. Palmer;Thomas E. Merchant;Dana Wallace

  • Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

    Shawna L. Palmer;Olga Goloubeva;Wilburn E. Reddick;John O. Glass

  • Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy

    Tanya M. Tekautz;Christine E. Fuller;Susan Blaney;Maryam Fouladi

  • Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.

    Charles G. Eberhart M.D.;James L. Kepner;Patricia T. Goldthwaite;Larry E. Kun

  • Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

    John F. Kuttesch;Leonard H. Wexler;Robert B. Marcus;Diane Fairclough

  • Primary malignant lymphoma of the central nervous system: Results of treatment of 11 cases and review of the literature

    Kevin Murray;Larry Kun;James Cox

  • Risks of Young Age for Selected Neurocognitive Deficits in Medulloblastoma Are Associated With White Matter Loss

    Raymond K. Mulhern;Shawna L. Palmer;Wilburn E. Reddick;John O. Glass

  • Craniopharyngioma: The St. Jude Children's Research Hospital experience 1984-2001

    Thomas E Merchant;Erin N Kiehna;Robert A Sanford;Raymond K Mulhern

  • Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma

    Amar Gajjar;Roberto Hernan;Mehmet Kocak;Christine Fuller

Frequent Co-Authors

Thomas E. Merchant
Thomas E. Merchant St. Jude Children's Research Hospital
Amar Gajjar
Amar Gajjar St. Jude Children's Research Hospital
James M. Boyett
James M. Boyett St. Jude Children's Research Hospital
Melissa M. Hudson
Melissa M. Hudson St. Jude Children's Research Hospital
Henry S. Friedman
Henry S. Friedman Duke University
Raymond K. Mulhern
Raymond K. Mulhern St. Jude Children's Research Hospital
Peter C. Burger
Peter C. Burger Johns Hopkins University
Roger J. Packer
Roger J. Packer Children’s National Health System
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Ian F. Pollack
Ian F. Pollack University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about expanding your healthcare career outside of traditional medical school? There are several flexible online degree options that can help you advance in the field, whether you’re just starting out or looking to specialize.

For registered nurses, exploring online dnp programs can lead to the highest level of nursing practice with the convenience of distance learning. If you aim to enter the workforce quickly, a 9 month lpn program offers a fast-paced route to becoming a Licensed Practical Nurse.

Mental health is another growing field, and professionals can become nurse practitioners by enrolling in a msn to pmhnp online program to support those with psychiatric needs. For those interested in the business side of healthcare, earning a health care administration online degree prepares you for leadership and management roles in hospitals or clinics.

These pathways allow you to balance work and study, and they can open new career doors—even if you’re not pursuing a traditional MD degree.

Best Scientists Citing Larry E. Kun

Recently Published Articles